Publications by authors named "Wouter Touwslager"

Claim this Profile
I
Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results.
Lian F van der Gang, Keneshka Atash, Nicolaas P A Zuithoff, Inge Haeck, Celeste M Boesjes, Wouter R H Touwslager

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry.
Lian F van der Gang, Celeste M Boesjes, Nicolaas P A Zuithoff, Inge Haeck, Octavian Bacoş-Cosma, Wouter R H Touwslager

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels.
Coco Dekkers, Nicolaas Zuithoff, Daphne Bakker, Edward Knol, Anne Wevers, Wouter Touwslager

Allergy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis.
Celeste M Boesjes, Esmé Kamphuis, Marlies de Graaf, Lotte S Spekhorst, Inge Haeck, Wouter R H Touwslager

JAMA Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
Junfen Zhang, Celeste M Boesjes, Laura Loman, Esmé Kamphuis, Margreet L E Romeijn, Wouter R H Touwslager

J Am Acad Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Lotte S Spekhorst, Celeste M Boesjes, Laura Loman, Nicolaas P A Zuithoff, Daphne S Bakker, Wouter R H Touwslager

Br J Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.
Lotte S Spekhorst, Marlies de Graaf, Nicolaas P A Zuithoff, Juul M P A van den Reek, Marijke Kamsteeg, Wouter R H Touwslager

JAMA Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phacopower modulation and the risk for postoperative corneal decompensation: a randomized clinical trial.
Muriël Doors, Tos T J M Berendschot, Wouter Touwslager, Carroll A Webers, Rudy M M A Nuijts

JAMA Ophthalmol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissatisfaction after implantation of multifocal intraocular lenses.
Niels E de Vries, Carroll A B Webers, Wouter R H Touwslager, Noel J C Bauer, John de Brabander

J Cataract Refract Surg· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis